You are here

Novartis

ESMO: Novartis parses long-awaited survival data for breast cancer blockbuster hopeful Piqray

Fierce Pharma

Sat, 09/19/20 - 09:12 pm

BioNTech acquires German manufacturing site to boost COVID-19 vaccine production

Biopharma Reporter

Thu, 09/17/20 - 10:48 am

Novartis says Beovu matched rival Eylea in visual acuity in eye disease

Pharma Live

Mon, 09/14/20 - 10:41 am

diabetic macular edema

clinical trials

After Novartis left, Boehringer bets up to $500M on the field of prescription smartphone app

Endpoints

Fri, 09/11/20 - 10:44 am

Boehringer Ingelheim

digital therapeutics

Click Therapeutics

Novartis, Roche fined $526M in France for alleged Lucentis marketing missteps

Fierce Pharma

Wed, 09/9/20 - 10:59 am

anti-competitive scheme

Big pharma spinouts grow up

EP Vantage

Tue, 09/8/20 - 10:53 am

In the footsteps of AstraZeneca, Novartis commits to carbon-neutral supply chain by 2030

Endpoints

Tue, 09/1/20 - 11:06 am

carbon neutrality

environmental concerns

Novartis targets Alexion's fiefdom after showing PNH patients can safely switch from Soliris

Fierce Biotech

Mon, 08/31/20 - 08:54 pm

clinical trials

Alexion Soliris

ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one

Fierce Pharma

Mon, 08/31/20 - 10:20 am

Novartis puts spokesceleb Cyndi Lauper in host chair for life-with-psoriasis podcast

Fierce Pharma

Sat, 08/29/20 - 11:38 pm

celebrity endorsements

Novartis’ ABL001 meets primary endpoint of phase 3 chronic myeloid leukemia study

Pharmaceutical Business Review

Thu, 08/27/20 - 11:01 am

clinical trials

chronic myeloid leukemia

Blow for Novartis as PD-1 drug spartalizumab flunks trial

Pharmaforum

Sun, 08/23/20 - 06:28 pm

clinical trials

Novartis set to take on Roche as FDA clears first at-home, injectable MS drug

Biopharma Dive

Thu, 08/20/20 - 10:52 pm

multiple sclerosis

Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA

Endpoints

Wed, 08/19/20 - 11:45 pm

New England Journal of Medicine

U.S. court upholds patent for Novartis MS drug Gilenya

Reuters

Tue, 08/18/20 - 11:04 am

multiple sclerosis

These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?

Motley Fool

Sun, 08/16/20 - 10:40 pm

artificial intelligence

drug development

Five Top Drugmakers Reveal List vs. Net Price Gaps

Drug Channels

Tue, 08/11/20 - 01:17 pm

Novartis says CAR-T cancer therapy works in second lymphoma type

BioPharma Dive

Tue, 08/4/20 - 12:40 pm

follicular lymphoma

Novartis’ Ilaris unexpectedly slashes need for joint replacements from osteoarthritis in key study

Fierce Biotech

Mon, 08/3/20 - 11:45 pm

joint replacements

Sangamo and Novartis Enter Agreement to Focus on Neurodevelopmental Diseases

BioSpace

Thu, 07/30/20 - 11:23 pm

Sangamo Therapeutics

gene regulation therapies

neurodevelopmental disorders

Pages